Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 19130960.
- Also identified by DOI 10.1016/j.otohns.2008.10.033.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate the dosage consistency of botulinum toxin injections in patients with long-term treatment for laryngeal dystonia. Chart review. Patients with laryngeal dystonia who had received at least 20 injections to the thyroarytenoid muscle were selected. Change of botulinum toxin dose, patient-reported effective weeks, and intervals between injections were investigated; data from the first five injections were excluded to eliminate initial dose titration. Fifty-five patients with an average follow-up of 12.5 years were identified. Mean dose of botulinum toxin was 2.37 +/- 1.6 U at the sixth injection; there was a decrease in mean dose over time, which became statistically significant at the 13th injection with a mean dose of 2.02 +/- 1.16 U. Mean duration of good effect and treatment intervals showed no significant change over time. Botulinum toxin dose needed for a constant response in treatment of laryngeal dystonia decreases over time, without any accompanying change in effective weeks and intervals.
Medical subject headings
- Botulinum Toxins
- Dystonia
- Laryngeal Diseases